• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Overdiagnosis of ADHD
Research Update

Overdiagnosis of ADHD

November 1, 2024
Alvin Marquez, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Alvin Marquez, MD. Dr. Marquez has no financial relationships with companies related to this material.

Getting your Trinity Audio player ready...

REVIEW OF: Harrison et al, J Atten Disord 2023;27(12):1343–1359

STUDY TYPE: Systematic review

When a patient presents with a positive score on an ADHD screener, how much weight should we give the test? Overreliance on self-report may lead to overdiagnosis of adult ADHD. This study aimed to describe the psychometric properties of commonly used ADHD screening tools to help clinicians interpret results. 

The authors conducted a systematic review, including 20 studies of several self-report measures, such as the Adult ADHD Self-Report Scale. They looked at sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) to see how well the tests separated ADHD from both healthy adults and symptomatic non-ADHD adults. False positives are expected with screening tools, which are designed to be more sensitive (that is, catching those who need further evaluation) than specific (that is, identifying those who don’t). 

Surprisingly, none of the studies used a comprehensive “gold standard” evaluation to verify the diagnosis. Many instead relied on other self-reports, often with high false positive rates. PPV scores were poor, particularly in clinical settings, where most tests had scores below 30%. In other words, a positive result for most tests had less than a coin flip’s chance of correctly identifying ADHD. Conversely, nearly every measure exhibited an NPV score of 95% or more, meaning a negative result rarely missed true ADHD, even in the presence of comorbid psychiatric conditions. This held true for most tests, except for two that focused on patients undergoing substance use treatment. Because the DSM criteria for ADHD include domains not captured by most self-reports (such as childhood onset and functional impairment), it is perhaps unsurprising that diagnosing by self-report alone is not reliable.

CARLAT TAKE 

While a negative result on an ADHD screener helps rule out the diagnosis, a positive result doesn’t tell us that the patient has ADHD. To diagnose adult ADHD, first rule out other causes. Seek ­third-party input and look for symptoms that date back to childhood (before age 12), are stable through time, and cause specific problems in multiple areas of life.

General Psychiatry
KEYWORDS ADHD overdiagnosis
    Alvin Marquez, MD

    More from this author
    www.thecarlatreport.com
    Issue Date: November 1, 2024
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Deprescribing, TCPR, November/December 2024
    Vyvanse Goes Generic: An Amphetamine Apart
    Azstarys: Vyvanse’s Dexmethylphenidate Cousin
    How to Stop a Psychiatric Med
    Antipsychotics Reconsidered
    Esketamine vs Quetiapine in ­Treatment-Resistant Depression
    Lithium, Valproate Have Low (and Similar) Risk of Kidney Injury
    Overdiagnosis of ADHD
    Estrogen in Schizophrenia
    CME Post-Test, Deprescribing, TCPR, November/December 2024
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.